Dapsone labels and packages: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
Line 46: Line 46:
|-
|-
|}
|}
{|
|-
| [[File:|800px|thumb]]
|-
|}


==References==
==References==

Latest revision as of 22:50, 9 January 2014

Dapsone
DAPSONE® FDA Package Insert
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Overdosage
Dosage and Administration
How Supplied
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Chetan Lokhande, M.B.B.S [2]

Labels And Packages

Principal Display Panel – 25 mg Carton Label

NDC 49938-102-30

DAPSONE

Tablets USP

25 mg

30 Tablets (2 x 15 unit of use)

Rx Only

To be sold as a single unit

[[File:|800px|thumb]]

Principal Display Panel – 100 mg Carton Label

NDC 49938-101-30

DAPSONE

Tablets USP

100 mg

30 Tablets (2 x 15 unit of use)

Rx Only

To be sold as a single unit[1]

[[File:|800px|thumb]]
[[File:|800px|thumb]]


References

  1. "DAPSONE TABLET [JACOBUS PHARMACEUTICAL COMPANY, INC.]".

Adapted from the FDA Package Insert.